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Abstract: The aim of the current study was to investigate the effects of the prepartum external
treatment of teats with a combination of four lactic acid bacteria strains viz. Lactobacillus (Lb.)
rhamnosus ATCC 7469, Lactococcus lactis subsp. lactis ATCC 11454, Lb. paracasei 78/37 (DSM 26911),
and Lb. plantarum 118/37 (DSM 26912) on the postcalving udder health of dairy heifers. The study
used a split-udder design. Two weeks before the expected calving date, one of two contralateral teats
of a teat pair was dipped with an aqueous suspension of lactic acid bacteria (final bacterial counts
8.40–8.47 log10-transformed CFU/mL) once in a week until calving; the other teat of the pair was not
treated. After calving, quarter foremilk samples were taken and investigated cyto-microbiologically.
In total, 629 teat pairs of 319 heifers were included. There was an association between the treatment
and intramammary infections caused by the major udder-pathogenic bacteria Staphylococcus aureus,
Streptococcus dysgalactiae, and enterococci, as well as clinical mastitis in the first 100 days after calving.
The present study indicates that intramammary infections with major pathogens and clinical mastitis
may be prevented by regular prepartum external application of lactic acid bacteria in dairy heifers.
Keywords: lactic acid bacteria; dairy heifers; intramammary infections; prevention
1. Introduction
‘Bovine mastitis’ is one of the most important diseases in modern high-yielding dairy herds [1],
causing annual economic losses of up to approximately € 1.4 billion in Germany [2]. Heifer mastitis
can cause a reduction of the life milk yield of dairy cows and affect culling risk [3,4].
Most of the mastitis-causing microorganisms invade the mammary parenchyma through the teat
canal [5]. Krömker and Friedrich found that in heifers, 77% of intramammary infections at parturition
established in the previous period [3]. The authors concluded that the opening of the teat canal before
calving is associated with heifer mastitis. In addition, the incidence of clinical mastitis during the
first lactation is influenced largely by the duration of infection ante partum and the mastitis pathogen
involved [3]. In New Zealand, Parker et al. observed a precalving gland prevalence of intramammary
infections (IMIs) of 15.5% in dairy heifers [6]. De Vliegher et al. in their article stated that the prevalence
of precalving IMI ranges from 29% to 75% of quarters in heifers and the prevalence of postcalving from
12% to 57% or higher [4]. Piepers et al. found that at least one quarter of approximately 80% of fresh
heifers was culture-positive [7]. They identified nonaureus staphylococci (NAS) as the most prevalent
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pathogens, followed by aesculin-positive streptococci and Staphylococcus (Staph.) aureus. However,
the study of De Vliegher et al. indicates that the presence of NAS have a protective effect against IMI
with major pathogens after calving [8].
As a major risk for heifer mastitis, the premature loss of the keratin plug of the teat canal
is suggested [9]. The precalving infusion of a bismuth subnitrate-based teat sealant reduces the
prevalence of postcalving IMI and the incidence of clinical mastitis [10]. Sampimon et al. showed that
the prepartum application of dry cow antibiotics could be a suitable approach to reduce the prevalence
of mastitis-causing pathogens at calving and the following 10 to 14 days [11]. Lopez-Benavides et al.
found that the precalving application of an iodine-based teat sanitizer results in the reduction of the
prevalence of IMI caused by Streptococcus (Strep.) uberis in the first week of calving [12].
Recently, the applications of probiotic bacteria in livestock farming have been discussed as a novel
approach to prevent bovine mastitis and to reduce the use of antibiotics [13,14]. Some selected strains
of lactic acid bacteria are capable of inhibiting the growth of mastitis-causing pathogens in vitro [15–17].
Klostermann et al. found that the efficiency of Lactococcus (Lc.) lactis DPC3147 may be equivalent to the
antibiotic therapy in the treatment of mastitis [18]. Furthermore, several other studies showed that the
infusion of lactic acid bacteria into the bovine udder may stimulate the host immune response [19,20].
The aim of the present study was to investigate the effects of the prepartum application of a teat dip
containing a combination of the four lactic acid bacterial strains viz. Lactobacillus (Lb.) rhamnosus ATCC
7469, Lb. paracasei 78/37 (DSM 26911), Lb. plantarum 118/37 (DSM 26912), and Lc. lactis subsp. lactis
ATCC 11454 on the udder health of dairy heifers after calving. The antimicrobial properties of the used
strains were described by Diepers et al. [17].
2. Results
In total, 629 teat pairs from 319 dairy heifers were included in the study. Of the treated quarters,
261 teats were treated once, 255 teats twice, and 113 teats minimum thrice (and up to maximum
five times).
After calving, no mastitis-causing pathogen could be isolated from 585 untreated (93.0%) and 595
treated quarters (94.6%), respectively (Table 1). In each treatment group (untreated, treated), NAS were
isolated from each 22 quarters (each 3.5%) as the most prevalent mastitis-causing pathogens, and Staph.
aureus was detected in 19 untreated (3.0%) and 11 treated quarters (1.8%), respectively.
The somatic cell counts were recorded in the range between 3.48 and 7.29 log10 (somatic cells/mL)
(median: 5.20 log10 (somatic cells/mL)) at point C1, and in the range between 3.30 and 7.33 log10
(somatic cells/mL) (median: 4.72 log10 (somatic cells/mL)) at point C2. At C1, the somatic cell count of
quarter foremilk samples from 378 untreated and 363 treated quarter was ≥100,000 somatic cells/mL,
and at C2, 213 untreated and 221 treated quarters showed a somatic cell count of ≥100,000 somatic
cells/mL.
In the first 100 days of calving, 22 cases of clinical mastitis were reported in 22 untreated teats
of 19 heifers, 10 cases in teats treated once in 10 teat pairs of 9 heifers, and one case was reported in
the group of teats treated twice. In one heifer, clinical mastitis occurred in both quarters of a teat pair,
of which one teat was treated only once.
The IMIs caused by the major pathogens Staph. aureus, Strep. dysgalactiae, and enterococci as well
as clinical mastitis in the first 100 days of lactation were associated with the frequency of treatments.
The odds ratio for IMIs caused by major pathogens was 14.5 (95% CI: 1.8–114.7) in quarters treated
mostly once compared to those treated at least twice, and the odds ratio for clinical mastitis was 13.6
(95% CI: 1.8–102.9) in quarters treated mostly once. At C1, the detection of major pathogens was
associated with the frequency of treatments (no or 1 × precalving application vs. ≥ 2 × precalving
applications, p = 0.003); at C2, the association tended to be statistically significant (p = 0.076). There were
not found any association between the application of the teat dip and both IMIs and log10-transformed
somatic cell counts (p > 0.05). In addition, the farm was not associated with the outcomes.
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Table 1. Postcalving microbiological results for untreated and treated quarters.
Pathogen Causing
Intramammary
Infection (IMI)
Untreated
Quarters (n = 629)
n (%)
Treated Quarters a (n = 629)
1 ×
Precalving
Application
n (%)
2 ×
Precalving
Applications
n (%)
3 ×
Precalving
Applications
n (%)
4 ×
Precalving
Applications
n (%)
5 ×
Precalving
Applications
n (%)
no growth 585 (93.0%) 245 (93.9%) 237 (92.9%) 99 (100.0%) 10 (100.0%) 4 (100.0%)
NAS b 22 (3.5%) 6 (2.3%) 16 (6.3%)
Staph. aureus 19 (3.0%) 10 (3.8%) 1 (0.4%)
Strep. dysgalactiae 2 (0.3%)
Enterococcus spp. 1 (0.2%) 1 (0.4%)
Total 629 261 255 99 10 4
a: one application of the teat dip per week; starting two weeks before the expected calving date. b: nonaureus
staphylococci/coagulase-negative staphylococci.
3. Discussion
The aim of the present study was to investigate the effects of the prepartum external application
of a teat dip containing live lactic acid bacteria in dairy heifers. The results show that the treatment
of udder quarters prevents IMIs with the major pathogens Staph. aureus, Strep. dysgalactiae, and
Enterococcus spp. in the first two weeks of the lactation as well as clinical mastitis in the first 100 days
of lactation.
Due to the relevance of heifer mastitis in dairy farms [4], the study emphasized the investigation
of the effect of the prepartum application of a teat dip on the postcalving udder health in dairy heifers.
The split-udder design of this study allowed eliminating an individual animal effect [21]. According
to Diepers et al., the used combination of all the four lactic acid bacteria viz. Lb. rhamnosus ATCC
7469, Lc. lactis subsp. lactis ATCC 11454, Lb. paracasei 78/37 (DSM 26911), and Lb. plantarum 118/37
(DSM 26912) was capable of inhibiting the growth of the (facultatively) pathogenic bacteria such as
Staph. aureus, Staph. epidermidis, Staph. xylosus, Strep. uberis, Strep. Agalactiae, and E. coli under in vitro
conditions [17]. Furthermore, these lactic acid bacterial strains were capable of adhering to bovine teat
canal epithelial cells. The authors proposed that lactic acid bacteria have the potential to be explored
as probiotics in preventing and treating IMIs.
The NAS were the most frequently isolated pathogens, followed by the major pathogens Staph.
aureus, Strep. dysgalactiae, and enterococci. The major pathogens were isolated from a small group
of quarters (2.7% of the subject quarters). Piepers et al. found that in approximately 80% of heifers,
pathogens could be isolated from at least one quarter [7]. The NAS and aesculin-positive streptococci
were identified as most frequent pathogens. In Germany, Krömker and Friedrich isolated NAS (13% of
quarters) and Staph. aureus (2%) as the most frequent microorganisms from foremilk samples in the
first five days of calving [3]. They reported that, in heifers, most of the IMIs at calving are established
in the early period. In addition, teat skin and teat canal of heifers may act as a reservoir, especially,
for staphylococci [8,22–25]. Despite the high proportion of udder quarters with somatic cell counts
≥ 100,000 somatic cells/mL (at C1 58.9% of all quarters, at C2 34.5%), intramammary infections were
detected in only 6.2% (78/1258; Table 1) of all quarters. This could be due to the conservative definition
of intramammary infections (detection of the same pathogen at day 7 ± 2 and day 14 ± 2 after calving)
according to Kiesner et al. [26]. Fifty nine percent of streptococcal IMI and 69% of coliform IMI had a
duration of at maximum 30 days during lactation [27].
In general, lactic acid bacteria produce certain metabolites such as organic acids, hydrogen peroxide,
diacetyl, bacteriocins, and other substances, which may inhibit the growth of other microorganisms [28,29].
Bouchard et al. concluded that strains with high adhesion and invasion potential may compete with
pathogens to colonize the bovine mammary gland tissue [16]. In the current study, the strains of lactic
acid bacteria were applied topically on the teat, and therefore it can be hypothesized that the lactic
acid bacteria may be established on teat skin and teat canal epithelium. Subsequently, the lactic acid
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bacteria may compete with mastitis-causing pathogens, which contaminate or are able to colonize teat
epithelia [12,22,24,30,31], and as a consequence, may reduce the pathogen burden on the mammary
gland. Interestingly, in the present study, the application of lactic acid bacteria did not affect the
IMIs caused by minor-pathogenic NAS, which indicates that on teat epithelia, NAS that are a part
of “normal” skin flora [32,33] could outcompete the selected strains of lactic acid bacteria. However,
our findings show that a regular application may be essential to establish the lactic acid bacteria on
teat epithelia and to achieve a medium- to the long-term protective effect on udder health. Since the
milk samples from mastitic quarters were not investigated to identify mastitis-causing pathogens, the
association between IMIs at the beginning of lactation and the clinical cases of mastitis during lactation
could not be determined. Krömker and Friedrich found that in heifers, about 85% cases of clinical
mastitis observed in the first 100 days of lactation occurred in quarters, which had an open teat canal
10 days before calving [3]. The findings of the present study are in accordance with the conclusion of
Krömker and Friedrich [3] that the avoidance of colonization of the mastitis-causing pathogens on
mammary glands could minimize the risk of heifer mastitis.
In the present study, no association between the application of the teat dip and the somatic
cell count as an indicator for the inflammatory status of an udder quarter [32] was found despite
the observed effects of the application of the teat dip on intramammary infections caused by major
pathogens. It is hypothesized that the application of the teat dip may stimulate the immune response,
but further research is needed to understand the interactions between the used lactic acid bacteria
strains and other components of the teat dip and the host. In several studies, immunomodulatory
effects have been reported after the application of lactic acid bacteria into the bovine mammary gland.
According to Beecher et al., a localized immune response is stimulated after the infusion of Lc. lactis
DPC 3147 into the mammary gland [20]. Crispie et al. observed an increase in neutrophils incorporation
into the udder within 48 h after the infusion of a live Lc. lactis culture [19]. The intramammary infusion
of Lb. perolens CRL 1724 at drying-off leads to the incorporation of neutrophils to the epithelial zone of
the cistern [34].
4. Materials and Methods
4.1. Herds and Animals
The study was conducted on German Holstein black pied cows in five commercial dairy farms
in Northern and Central Germany. The average size of the herds ranged from 154 to 1539 lactating
cows, producing average milk yields between 7300 and 11,176 kg per cow. The cattle were housed in
free-stall barns with cubicles or in straw-bedded pens. The udder health of the included dairy herds
was characterized by a high rate (41% to 61%) of annual heifer mastitis (heifers with more than 100,000
somatic cells/mL at first DHI sampling in all calved heifers per year). No pharmaceutical agent was
used for the prevention of heifer mastitis. Only clinically healthy pregnant heifers with four teats
appearing functional without injuries or signs of cured injuries were included in the trial.
4.2. Experimental Design
The study used a split-udder design. Two weeks before the expected calving date, two researchers,
well-trained in treating and sampling procedures, started dipping randomly, based on a computer
generated random list, either the left front and the right hind teat or the right front and the left hind teat
of dairy heifers in the teat dip suspension containing live lactic acid bacteria once a week until calving.
We have chosen a dip interval of one week, as we were able to isolate the relevant microorganisms
back from the tip of the teat up to one week after dip in various preliminary tests. A conventional dip
cup without back flow was used for all treated teats in one herd. The treated teats were dipped briefly
(1 second) in the solution, as with a commercial dipping agent. The teats were not washed, cleaned,
or dried before application.
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The contralateral teats were not treated with the teat dip during the study period. A treated teat
was matched with its contralateral untreated teat to minimize individual animal effects [21].
The foremilk samples were taken aseptically from all quarters of the animals included in the study
at day 7 ± 2 (C1) and 14 ± 2 (C2) after calving.
All applicable guidelines for the care and use of animals were followed. The study was approved
by the animal welfare committee of the university (Az1623). An application for a license for animal
testing was not required by the local government due to the external use of GRAS microorganisms.
The study meets the International Guiding Principles for Biomedical Research Involving Animals (1985).
4.3. Preparation of Teat Dip
In addition to the standard strains Lb. rhamnosus ATCC 7469 and Lc. lactis subsp. lactis ATCC
11454, two wild strains Lb. paracasei 78/37 (DSM 26911) and Lb. plantarum 118/37 (DSM 26912) were also
used, which were isolated and characterized at the University of Applied Sciences and Arts Hannover
by Diepers et al. [17] and Wallis et al. [35]. The noncommercial teat dip suspension was prepared
one day before application. The individual strain was cultured in 50 mL MRS broth (Oxoid, Wesel,
Germany; the pH was adjusted to 5.5 by adding lactic acid) and incubated at 37 ◦C for 72 h. Afterwards,
25 mL of the culture was centrifuged at 900 × g for 10 min. The bacterial pellet was resuspended in the
remaining 25 mL of noncentrifuged culture. The final teat dip suspension contained 19.75% (v/v) of
individually enriched strain in MRS broth, 20% of 10% skim milk powder solution, and 1% of a 10%
(w/v) filter sterilized chlorophyllin-copper complex solution (Caelo, Hilden, Germany) as a colorant.
The concentration of each strain before mixing was determined, and the ratio between the strains
was confirmed as equal for each strain. In the final teat dips, the total counts of lactic acid bacteria
ranged from 8.40 to 8.47 log10-transformed CFU/mL as detected on MRS agar (Applichem, Darmstadt,
Germany) after incubation at 37 ◦C for 48 h.
4.4. Sampling Procedure
As mentioned earlier, quarter foremilk samples were collected aseptically at C1 and C2. According
to NMC, after cleaning teats with dry paper towels, the first three streams of milk were discarded and
the teat ends were disinfected with 70% ethanol [36]. Approximately 10 mL of milk was collected per
quarter in duplicate into sterile tubes by two well-trained researchers. The samples were transported
at 5 ◦C to the microbiology lab at the University within eight hours, and were analyzed within two
hours of arrival by a trained blinded researcher.
4.5. Cyto-Microbiological Analysis and Definitions
For the microbiological diagnosis, 10 µL of a well-mixed quarter foremilk sample was plated
onto a quadrant of an aesculin blood agar plate (Oxoid, Wesel, Germany). The plates were
incubated aerobically at 37 ◦C and examined after 24 and 48 h, respectively, following the GVA
recommendations [37]. The colonies were identified by Gram staining, cell morphology, aesculin
hydrolysis, and hemolysis patterns. Catalase and Gram-positive cocci were identified as Staph. aureus
characterized by beta-hemolysis and having a positive clumping factor (Diamondial StaphPlus Kit,
Diamondial, Sées, France) reaction. Other staphylococci were referred to as NAS. Gram-positive
and catalase negative cocci were identified as streptococci. The modified Rambach agar was used to
differentiate the aesculin hydrolysing cocci [38]. Aesculin hydrolysing, β-D-galactosidase-positive
cocci were identified as Strep. uberis, and aesculin hydrolysing, β-D-galactosidase-negative cocci
were identified as Enterococcus spp. Aesculin-negative streptococci were further characterized by
Lancefield serotyping (group B streptococci: Strep. agalactiae, group C streptococci: Strep. dysgalactiae;
Diamondial Strep Kit, Diamondial, Sées, France). Gram-positive, asporogenic, beta-hemolytic, and
catalase-negative irregular rods with a V- or Y-shaped configuration were identified as Trueperella
(T.) pyogenes. Bacillus spp. were Gram-positive and catalase positive rods, which are able to form
endospores. Coliform bacteria were Gram-negative and cytochrome oxidase-negative (Bactident
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oxidase, Merck, Darmstadt, Germany) rod-shaped bacteria that were capable of fermenting glucose
(OF basal medium with the addition of D [+]-glucose monohydrate, Merck, Darmstadt, Germany).
On ChromoCult®Coliform Agar (Merck, Darmstadt, Germany), E. coli formed blue colonies, unlike
other coliforms that formed pink-red colonies. Pseudomonads were identified as Gram-negative,
catalase positive, cytochrome oxidase-positive rod-shaped bacteria that utilize glucose oxidatively (OF
test). Yeasts and Prototheca spp. were differentiated microscopically after subculture on YGC agar
(Merck, Darmstadt, Germany).
The samples were categorized as positive with a growth of a minimum of five colonies. However,
Staph. aureus, Strep. Agalactiae, and Strep. dysgalactiae were identified even if a single colony was
detected. If the growth of more than two different types of colonies was identified, the sample was
considered to be contaminated. However, the growth of Staph. aureus and Strep. dysgalactiae was
reported from contaminated samples.
Somatic cell counts of the milk samples were determined using a flow cytometer SomaScope
Smart (Delta Instruments B.V., Drachten, The Netherlands).
On the basis of the cyto-microbiological investigation of the quarter foremilk samples, a quarter
was considered infected if the same pathogen was detected in both C1 and C2 samples [26].
4.6. Data Analysis
The data were recorded using Microsoft Excel 2010 software (Microsoft, Redmond, WA, USA).
Somatic cell counts were expressed as log10-transformed. All statistical analyses were performed with
SPSS 26.0 (IBM, Armonk, NY, USA). The associations between the variables IMI (yes/no), IMI caused
by a major pathogen (pathogen other than NAS and Corynebacterium spp. [32]; yes/no), detection of a
major pathogen at C1 or C2, log10-transformed somatic cell counts at C1 and C2 and the occurrence
of clinical mastitis in the first 100 days after calving (e.g., clots/flakes in milk, swelling/redness of
udder; yes/no), and the fixed effects dipping (yes/no) and the number of treatments before calving
were investigated with the generalized linear mixed regression models for repeated measurements.
The subject was the teat pair consisting of a treated and its contralateral untreated teat. The farm was
treated as a random effect, and the statistical significance was accepted at p < 0.05.
5. Conclusions
In conclusion, the results of the present study indicate that the external application of lactic acid
bacteria on teats reduces the risk of IMIs with major pathogens at the beginning of lactation in heifers
as well as the risk for clinical mastitis in the first 100 days after calving. However, further research is
required to investigate the interactions between the lactic acid bacteria and mastitis-causing pathogens,
teat and udder epithelia, and their influence on host immune response.
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